USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Dupont Nutrition Biosciences APS

USPTO PatentsView assignee record - 102 granted patents across 50 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

102
Total patents granted
50
CPC technology areas
16.3
Avg claims per patent
-52%
5-year filing velocity

The verdict

Dupont holds 102 US patents across 50 technology areas, rank #3,593 of 50,000 tracked assignees.

#3,593
of 50,000 US assignees by volume
Top 6%
by Innovation Score (56.1/100)
16.3
avg claims per patent
-52%
filing velocity, last 5 yrs

Portfolio overview

Dupont Nutrition Biosciences APS has been granted 102 US utility patents between 2015 and 2024, placing Dupont Nutrition Biosciences APS at rank #3,593 across all assignees tracked by PlainPatent. This portfolio spans 50 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.3 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, Dupont Nutrition Biosciences APS is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Dupont sits between Bostik Sa (102 patents, rank #3,589) and Inficon Ag (102 patents, rank #3,597) - the closest US assignees by grant volume. The composite Innovation Score of 56.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 33 grants, compared with 69 in the 2015–2019 window, a -52% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Dupont Nutrition Biosciences APS's 16.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 50 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Dupont Nutrition Biosciences APS against peers pursuing similar technology classes.

Who files at Dupont's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Dupont holds 102 patents at rank #3,593, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Dupont

By rank, the assignees closest to #3,593 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Dupont's primary technology class.

Dupont's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

56 Top 6% higher than 94% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0510152025 2015201620172018201920202021202220232024 3
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Dupont Nutrition Biosciences APS patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 23 22.5%
2016 18 17.6%
2017 8 7.8%
2018 10 9.8%
2019 10 9.8%
2020 11 10.8%
2021 3 2.9%
2022 10 9.8%
2023 6 5.9%
2024 3 2.9%

Which technologies does Dupont Nutrition Biosciences APS patent most?

Top 15 of 50 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#3,593

Across all tracked assignees

Innovation Score

56.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Dupont Nutrition Biosciences APS hold?
Dupont Nutrition Biosciences APS holds 102 US granted patents filed between 2015 and 2024, spanning 50 technology areas.
What is Dupont Nutrition Biosciences APS's Innovation Score?
Dupont Nutrition Biosciences APS has an Innovation Score of 56.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Dupont Nutrition Biosciences APS focus on?
Dupont Nutrition Biosciences APS's top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 61 patents. The company has filed patents in 50 CPC subclasses total.
Is Dupont Nutrition Biosciences APS's patent filing rate increasing or decreasing?
Dupont Nutrition Biosciences APS's recent filing velocity is -52% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Dupont Nutrition Biosciences APS's patents?
Dupont Nutrition Biosciences APS's patents average 16.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the Dupont Nutrition Biosciences APS patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Dupont's 102 grants land it in the top 6% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Dupont ranks #3,593 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.